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Abstract
Background: In Sweden NRT-products and Snus, are easily available and used as smoking cessation aids. However,
most quit attempts are made without any cessation aids. The limited use of these products as cessation aids may
be influenced by the way smokers perceive the harmfulness of NRT-products and Snus compared to smoking. The
present study examines these perceptions and their association with perceptions of the harmfulness of nicotine
itself.
Methods: The study is based on the Swedish part of a two-nation web-based survey of daily smokers in Sweden
(n = 1016) and Norway (n = 1000). Questionnaire items addressed perceptions of NRT-products’ and Snus’
harmfulness and nicotine’s part of the health risks of smoking. Data analyses included cross-tabulations and logistic
regressions.
Results: A majority, 59% of the answers to the question about harmfulness of NRT-products, and 75% of the
answers about harmfulness of Snus, were inconsistent with the scientific evidence by demonstrating exaggerated
perceptions of harmfulness. The strongest predictor of consistent answers was the perception of the harmfulness
of nicotine. There were also significant associations with own experience of successful use of the products in
question. Overall the perceptions of the harmfulness of nicotine were considerably exaggerated. This pattern was
more pronounced among women than men. Prevailing misperceptions may be related to the way that different
tobacco and nicotine products are presented in the media and other publicly available information sources.
Conclusions: Public information about smoking and health should be expanded to include objective and
unambiguous information regarding nicotine’s part in the harmfulness of smoking and the harmfulness of different
nicotine-containing products compared to smoking.
This is essential in order to preclude that misperceptions regarding these matters could discourage smokers from
adopting effective cessation practices with use of nicotine-containing aids.
Background
Smoking cessation practices in Sweden
In the late 1970s the prevalence of daily smoking in
adult men in Sweden was about 40% and about 35% in
adult women [1]. In 2008 the prevalence had come
down to 11% among men and 14% among women [2].
This development reflects an expansion of smoking ces-
sation practices that has been influenced by several fac-
tors, for example the invention and pioneer use in
Sweden of products for nicotine replacement therapy
(NRT-products) and the use, mainly among men, of the
Swedish kind of oral smokeless tobacco, “Snus”,am o i s t
powder of finely ground tobacco leaves with low levels
of tobacco-specific nitrosamines. Male prevalence of
daily Snus use increased from around 10% to around
22% in the period from the late 1970s to the early 2000s
[1]. NRT-products were initially prescription-only medi-
cations but already in the late 1980s they became avail-
able over the counter in licensed pharmacies and from
March 2008 also in many other outlets like grocery
stores. Snus has always been sold in a large number of
outlets.
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d u c t sa n dS n u s ,a sa i d si ns m o k i n gc e s s a t i o nh a sb e e n
shown to increase the successfulness of quit attempts
[3-7]. All these products are easily available in Sweden
and they have been used as aids in many quit attempts.
Still, the majority of quit attempts in Sweden have been
made without use of any cessation aids [7,8]. The lim-
ited level of use of cessation aids could be influenced by
a number of conditions. One possible such condition
could be the way smokers perceive the harmfulness of
using NRT-products and Snus compared to smoking.
The purpose of this study is to examine both how
daily smokers in Sweden perceive the harmfulness of
using nicotine-containing products such as nicotine
gum/patch and Swedish Snus, and how they perceive
the harmfulness of nicotine itself. Further, the study
aims at examining how the harm perceptions of the use
of nicotine-containing products are associated with the
perception of nicotine’s harmfulness and other factors.
Methods
The current study, VAKT (Habits, Attitudes and Knowl-
edge about Tobacco), is based on the baseline survey of
the Swedish part of a prospective panel study of 1016
daily smokers in Sweden and 1000 daily smokers in
Norway, that was started in 2009 by the Research
Group for Societal and Information Studies (FSI) in
cooperation with the Norwegian institute for alcohol
and drug research (SIRUS) and Institute for Tobacco
studies (ITS).
The study has been approved by the Regional Ethics
Review Board in Stockholm, Dnr 2008/2003-31/5.
Sample selection and data collection
The study population consists of daily smokers born in
the period 1950 to 1989 (n = 1016). The participants
were recruited from Norstat Inc’s web population [9]. In
order to avoid selection bias in the sampling process the
participants were initially kept unaware that they were
recruited to a survey which focused on tobacco use.
Those who were identified as daily smokers were asked
to participate in a prospective study of their tobacco
behaviour. Data collection was done by a web based sur-
vey and the participants received approximately 10 SEK
($ 1.30) in compensation for completing the
questionnaire.
In order to ascertain the representativity of the sample
it was compared with the nationwide representative
database Your Country and Your Life (YCYL) with
regard to the proportion of men and women, education
levels and birth decades in daily smokers of the age
groups concerned. Some disparity was observed for the
proportion between men and women and for birth dec-
ades and the sample was weighted for sex and birth
decade. Table 1 shows frequency distributions for the
weighted study population, VAKT, and the reference
population, YCYL.
The questionnaire included questions constructed so
that the answers reflected the perception of harmfulness
of two kinds of nicotine-containing products (nicotine
gum/patch and Swedish Snus) and of nicotine itself.
Further there were questions aimed at studying a num-
ber of such personal and environmental factors that can
be assumed to influence the harm perceptions.
Each one of the questions regarding nicotine-contain-
ing products connected to a statement of opinion on
which conflicting views had been expressed in different
public information channels. The question that was
asked about each statement was:
Can you determine what is true and false? The word-
ings of the statements were:
“Long term use of nicotine from patches or gums is
almost as harmful to health as smoking”
“Snus use is almost as harmful to the health as
smoking”
In the continued text, the question about the first
statement is, for short, referred to as the NRT-question,
the second as the Snus-question.
The questions were answered by indicating “True” or
“False” or “Do not know”. Based on the consensus of
scientific opinion illustrated by various studies and
reports [10-16] we concluded that for both questions
the answer “False” is consistent with the scientific evi-
dence. For the purpose of data analysis the answers
were categorized according to whether they represented
presence or absence of an outspoken perception consis-
tent with the scientific evidence. Therefore, answer
“False” is hereafter referred to as Consistent,w h i l e
Table 1 Frequency distributions in the VAKT- and the
YCYL-population (in brackets)
Sex VAKT YCYL
Women 55.5% (54.3%)
Men 44.5% (45.7%)
Education level VAKT YCYL
Low 72.0% (78.2%)
High 28.0% (21.8%)
Birth decades VAKT YCYL
50s 34.0% (34.1%)
60s 24.5% (24.4%)
70s 16.5% (16.5%)
80s 25.0% (25.0%)
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consistent.
The question regarding the harmfulness of nicotine
was put in the context of how large part of cigarette
harm that should be attributed to the nicotine in the
smoke. In the continued text, this question is, for short,
referred to as the Nicotine-question. The wording was:
“According to you, how large part of the health risks
in smoking comes from the nicotine?”
The answers were coded into four categories: “None
or very small part”, “Relatively small part”, “Relatively
large part”, “Very large part or all”. According to the
consensus of scientific opinion expressed in, for exam-
ple, some of the sources mentioned above, the first two
answers are more correct than the two last ones.
Data analysis
Descriptive analyses by, cross-tabulations were per-
formed to examine the distribution of frequencies for
different answers among men and women.
Logistic regressions using SPSS 13.0 were performed
to calculate the odds ratios for consistent answers to the
NRT-question and the Snus-question controlling for
“Perception of nicotine’s part of the health risks in
smoking”, “Birth decade”, “Education level”, “Sex”,
“Desire to stop smoking”, “Place of residence”, “Time to
first cigarette”, “Previous use of NRT and benefits
thereof in attempts to quit smoking”, “Previous use of
Snus and benefits thereof in attempts to quit smoking”,
“Proximity to people that have used NRT in attempts to
quit smoking” and “Proximity to people that have used
Snus in attempts to quit smoking”.
Results
Descriptive analyses
Both in men and women a majority of the respondents
answered Not consistent on both the NRT-question and
the Snus-question. Both questions yielded larger propor-
tion of consistent answers from men than from women.
For details, see Table 2.
Among women 37.3% answered “Don’tk n o w ” (subca-
tegory of Not consistent answers) to the NRT-question,
while the corresponding proportion of men is 40.2%.
For the Snus-question the proportion answering “Don’t
know” is 12.0% for women and 20.7% for men.
The answers to the Nicotine-question demonstrate
considerably exaggerated perceptions of the harmfulness
of nicotine. This pattern is more pronounced among
women than among men. For details, see Table 3.
Regression analyses
The results from the regression analyses are presented
in Table 4.
The answers to the NRT-question were most strongly
influenced by the perception of nicotine’sp a r to ft h e
health risks in smoking. Among those who (correctly)
perceived nicotine’s harmfulness as low, the likelihood
of Consistent answer to the NRT-question was about
four times as high as among those who perceived nico-
tine’s harmfulness as high. Among those with high edu-
cation level the likelihood of a Consistent answer to the
NRT-question was almost double as high as among
those with low education. Similarly, residence in a main
city was associated with higher likelihood of Consistent
answer than residence in rural areas. Successful previous
use of NRT in attempts to quit smoking, as well as
proximity to people that had successfully used Snus in
attempts to quit smoking, also had an association with
Consistent answers to the NRT-question.
The answers to the Snus-question were also most
strongly influenced by the perception of nicotine’sp a r t
of the health risks in smoking. Among those who per-
ceived nicotine’s harmfulness as low, the likelihood of
Consistent answer to the Snus-question was about three
times as high as among those who perceived nicotine’s
harmfulness as high. Birth in the 1980s was associated
with slightly higher likelihood of Consistent answer than
birth in the 1950s, and men were more likely than
women to give Consistent answers. Highest level of nico-
tine dependence (< 5 minutes to first cigarette) was
associated with higher likelihood of Consistent answer
Table 2 Answers to the NRT-question and Snus-question
for women and men
NRT-question Snus-question
Sex Sex
Women Men Total Women Men Total
Not consistent 62.1% 55.3% 59.1% 81.6% 65.8% 74.5%
Consistent 37.9% 44.7% 40.9% 18.4% 34.2% 25.5%
n = 549 445 994 549 445 994
Missing values 15 7 22 15 7 22
Table 3 Answers to the Nicotine-question for women and
men
Nicotine’s part of the
health risks of smoking
Sex
Women Men Total
None or very small part 8.5% 22.1% 14.6%
Relatively small part 26.2% 36.3% 30.7%
Relatively large part 35.6% 25.2% 31.0%
Very large part or all 29.6% 16.4% 23.7%
n = 550 444 994
Missing values 15 7 22
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and Snus
Long term use of nicotine
from patches or gums is
almost as harmful to
health as smoking.
Snus use is almost as
harmful to the health
as smoking.
Predictors p-value OR 95% C.I. p-value OR 95% C.I.
Perception of nicotine’s part of the health risks in smoking
None or very small part (ref) 1 1
Relatively small part 0.01 0.48 0.29-0.80 0.00 0.44 0.26-0.75
Relatively large part 0.00 0.20 0.12-0.35 0.00 0.30 0.17-0.54
Very large part or all 0.00 0.25 0.14-0.43 0.00 0.33 0.18-0.61
Birth decade
80 s (ref) 1 1
70s 0.17 0.70 0.43-1.16 0.29 0.75 0.44-1.28
60s 0.97 0.99 0.63-1.56 0.52 0.85 0.52-1.39
50s 0.46 1.19 0.76-1.86 0.10 0.65 0.39-1.08
Education level
Low (ref) 1 1
High 0.00 1.88 1.34-2.64 0.19 1.30 0.88-1.93
Sex
Women (ref) 1 1
Men 0.22 1.23 0.89-1.70 0.05 1.43 0.10-2.07
Desire to quit smoking
No desire (ref) 1 1
Some desire 0.80 0.92 0.47-1.80 0.60 1.23 0.57-2.65
Strong desire 0.93 1.03 0.51-2.09 0.80 0.90 0.40-2.03
Place of residence
Rural areas (ref) 1 1
Small city 4’-30’ 0.16 1.37 0.88-2.13 0.31 0.76 0.45-1.29
Large city >30’ 0.90 1.03 0.66-1.62 0.55 1.17 0.70-1.96
Main city 0.03 1.65 1.05-2.57 0.47 1.21 0.72-2.02
Time to first cigarette (after waking up)
>30 minutes (ref) 1 1
6-30 minutes 0.68 1.07 0.77-1.50 0.03 1.57 1.05-2.35
> 5 minutes 0.76 1.07 0.68-1.70 0.01 2.03 1.20-3.42
Previous use of NRT and benefits thereof in attempts to quit smoking
Not used (ref) 1 1
Used, none or modest benefit 0.70 1.08 0.74-1.55 0.02 0.61 0.40-0.94
Used, quite a large benefit or helped completely 0.01 1.71 1.14-2.57 0.17 0.72 0.45-1.15
Previous use of Snus and benefits thereof in attempts to quit smoking
Not used (ref) 1 1
Used, none or modest benefit 0.37 0.81 0.51-1.28 0.00 3.11 1.92-5.04
Used, quite a large benefit or helped completely 0.95 1.01 0.67-1.53 0.00 3.88 2.50-6.01
Proximity to people that have used NRT in attempts to quit smoking
No proximity (ref) 1 1
Proximity to unsuccessful attempts 0.45 1.17 0.78-1.76 0.68 1.10 0.69-1.77
Proximity to successful attempts 0.76 1.07 0.70-1.63 0.74 1.09 0.66-1.79
Proximity to people that have used Snus in attempts to quit smoking
No proximity (ref) 1
Proximity to unsuccessful attempts 0.37 1.22 0.79-1.87 0.38 0.80 0.48-1.33
Proximity to successful attempts 0.01 1.60 1.11-2.32 0.39 1.20 0.79-1.85
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Snus in attempts to quit smoking also had a strong
association with Consistent answers to the Snus-
question.
The predictors “Birth decades” and “Desire to stop
smoking” had no significant association with either the
NRT-question or the Snus-question. Men and women do
not differ significantly with regard to the NRT-question,
while there is a borderline significance (at the 95% level)
for higher likelihood of Consistent answers to the Snus-
question f r o mm e nt h a nf r o mw o m e n .W i t hr e g a r dt o
the NRT-question, residents in main cities give Consis-
tent answers more often than residents in rural areas.
With regard to the Snus-question there are no differ-
ences between residence areas. Other predictors
included in the model did not show significant
associations.
Discussion
In this study we have asked questions to examine how
daily smokers in Sweden perceive the harmfulness of
using nicotine-containing products and how they per-
ceive the harmfulness of nico t i n ei t s e l f .T h ea n s w e r s
could be based either on correct or on false information
or on own experiences and/or environmental influences
of different kinds. Therefore the answers will in most
cases reflect “believed knowledge” rather than cogni-
zance of established evidence. But believed knowledge
can have, and in many cases has, equal consequences as
real knowledge, so as pointed out by W.I. Thomas in
the Thomas theorem: “If men define situations as real,
they are real in their consequences.” [17].
Overall, the findings reveal that Swedish smokers have
exaggerated perceptions of the harmfulness of nicotine
and nicotine-containing products. Similar findings have
also been reported in American studies. A study of col-
lege freshmen [18] found that around 20% of the
respondents did erroneously perceive nicotine gum/
patch to be as harmful as or more harmful than cigar-
ettes and almost 90% of them did erroneously perceive
smokeless tobacco products in the same way. Another
American study [19] highlighted the potential role of
exaggerated perceptions of the health risks of nicotine,
the key substance in all these products. For example did
around two thirds of the respondents erroneously
believe that nicotine causes cancer.
In the descriptive analysis we examined to what extent
the different harm perceptions were consistent with the
scientific evidence among men and women. We found
that a majority of Swedish daily smokers have a believed
knowledge, both about NRT-use and about Snus-use
harmfulness compared to smoking that is not consistent
with scientific evidence. Absence of correct believed
knowledge is more common for Snus use than for NRT
use. One possible interpretation could be that NRT-
products have gained some confidence by their status as
medicinal products. In both cases the absence of correct
believed knowledge is more common among women
then among men, the difference being larger for Snus
use than for NRT use. With regard to perceptions of
the harmfulness of nicotine itself the study does again
demonstrate a frequent absence of correct believed
knowledge. More than half, 54%, of the answers are on
the lesser correct half of the scale. Again, the absence of
correct believed knowledge is more common among
women then among men.
In the regression analyses we examined how the harm
perceptions of NRT-use and Snus use were associated
with a number of possible predictors. Among those pre-
dictors include in the regression model strong influences
were found for the perception of nicotine harm and
Own experience of successful use of the products in
question, while most others had weak or no association
(for details, see the Results section).
Ap e r s o n ’sp e r c e p t i o n so fap r o d u c to ras u b s t a n c e
can be seen as the outcome of an accumulated intake of
information and impressions from various sources.
According to the theories of Selective Exposure and
Selective Perception [20-22] people will tend to choose
which information to take note of and to adopt inter-
pretations that are preferable with respect to personal
conditions. This can, for example, make people who are
users of a certain product more likely to develop a posi-
tive perception of that product than non-users. This
kind of mechanisms may be part of the reason behind
the finding that men, a group with many Snus users,
have slightly higher ORs for consistent answers to the
Snus-question than women, a group with few Snus
users. The influence of personal conditions is further
illustrated by the findings that people with own experi-
ence of successful NRT use for smoking cessation have
higher ORs than non-users for consistent answers to the
NRT-question,j u s ta sa l lO R sf o rc o n s i s t e n ta n s w e r st o
the Snus-question a r eh i g h e ra m o n gt h o s ew i t ho w n
experience of Snus use for smoking cessation. Further,
an exaggerated perception of nicotine harm may, parti-
cularly among people without own experience of use of
nicotine products, increase the likelihood of selectivity
in choosing and interpreting various impressions in
such a way that supports a perception of nicotine pro-
ducts being a priori harmful.
T h eo u t c o m eo fap e r s o n ’s accumulated intake of
information will evidently first of all depend on what
information is available and understandable altogether.
In Swedish media there has been very modest coverage
of different NRT-products. Messages regarding Snus
often have a one-sided nature with main focus either on
pros or cons. A striking example of contradictory
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th of May 2007 in the two
major Swedish morning newspapers. Both reported an
article from The Lancet, one by saying: “Twice the risk
for Snus users to get cancer” [23] and the other by say-
ing “Snus can be beneficial for smokers” [24]. Overall,
the pictures about different tobacco and nicotine pro-
ducts presented in the media, as well as in other pub-
licly available information sources, are not concordant
and can be both confusing and misleading for the recei-
ver. We found that high education increases the likeli-
hood of consistent answers to the NRT-question.O n e
possible interpretation of this could be that education
constructs a ground that makes it easier to assess rele-
vant information about NRT-products. The finding that
high education does not influence the likelihood of con-
sistent answers to the Snus-question is consistent with
findings in an American study showing that university
staff members had no better knowledge than others
with regard to smokeless tobacco [25]. This might
reflect the lack of unambiguous information about Snus.
This interpretation is further supported by the overall
picture presented in Table 2 showing that consistent
answers are less frequent for the Snus-question than for
the NRT-question.
It appears that public information channels in Sweden
have failed to effectively communicate pertinent pieces
of correct information on nicotine and nicotine pro-
ducts. The findings from this study on nicotine and
NRT-products are consistent with those of American
studies [18,19], and analogous patterns are found for
Swedish Snus as well. It can be assumed that similar
patterns are prevailing in most countries. While further
research on these matters will be needed, the current,
widespread occurrence of false believed knowledge must
in any case be seen as an unfortunate situation. Percep-
tions of these kinds are likely to influence whether smo-
kers choose to use a nicotine-containing aid to try to
quit smoking, or choose to continue to smoke. As
pointed out in a recent study of different scenarios [26]
these choices are critical to the attainment of the goals
of reducing smoking prevalence. It will therefore be
essential to expand public, non-commercial information
on smoking and health to include comprehensive data
regarding the part nicotine plays in the harmfulness of
smoking as well as objective data on the harmfulness of
different nicotine-containing products compared to
smoking.
Conclusions
Overall there is a high degree of believed knowledge
regarding NRT-products and Snus that is not consistent
with scientific evidence and it is most strongly influ-
enced by the misbelief that nicotine plays a large part in
the harmfulness from smoking. It is therefore needed to
expand public, non-commercial information on smoking
and health to include comprehensive data regarding the
part nicotine plays in the harmfulness of smoking as
well as objective and unambiguous data on the harmful-
ness of different nicotine-containing products compared
to smoking. This is essential in order to preclude that
misperceptions regarding these matters could discourage
smokers from adopting effective cessation practices with
use of nicotine-containing aids.
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